Bio Preventive Medicine (ROCO:6810) ROCE %: -22.98% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6810 Bio Preventive Medicine Corp ROCO:6810
52 GF Score
Price NT$21.00
GF Value NT$27.53
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bio Preventive Medicine ROCE %?

Bio Preventive Medicine ROCO:6810 -1.18% 52 ROCE % is -22.98% as of Dec. 2025. GuruFocus rates ROCO:6810 with a GF Score™ of 52/100 and a GF Value™ of NT$27.53 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bio Preventive Medicine's annualized ROCE % for the quarter that ended in Dec. 2025 was -22.98%.

Bio Preventive Medicine  (ROCO:6810) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bio Preventive Medicine ROCE % Related Terms

Bio Preventive Medicine ROCE % Historical Data

* Premium members only.

The historical data trend for Bio Preventive Medicine's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Preventive Medicine ROCE % Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -38.85 -35.70 -28.22 -22.39 -21.31

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.49 -36.35 -24.78 -19.78 -22.98
ROCO:6810
52GF Score
Bio Preventive Medicine Corp ROCO:6810
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Preventive Medicine ROCE % Calculation

Bio Preventive Medicine's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-97.194/( ( (529.705 - 20.914) + (425.186 - 21.618) )/ 2 )
=-97.194/( (508.791+403.568)/ 2 )
=-97.194/456.1795
=-21.31 %

Bio Preventive Medicine's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-98.892/( ( (473.466 - 16.451) + (425.186 - 21.618) )/ 2 )
=-98.892/( ( 457.015 + 403.568 )/ 2 )
=-98.892/430.2915
=-22.98 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -22.98% mean?
Bio Preventive Medicine (ROCO:6810) has a ROCE % of -22.98% as of Dec. 2025.
Is Bio Preventive Medicine's ROCE % too high?
Bio Preventive Medicine's current ROCE % is -22.98%. Overall, Bio Preventive Medicine has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bio Preventive Medicine's ROCE % compare to VRTX and REGN?
Bio Preventive Medicine's ROCE % of -22.98% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Bio Preventive Medicine's current ROCE % is -22.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Preventive Medicine stock overvalued right now?
Based on GuruFocus' analysis, Bio Preventive Medicine (ROCO:6810) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$27.53, compared to a current price of NT$21.00 — trading 23.7% below its estimated fair value. The current ROCE % is -22.98%. Bio Preventive Medicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bio Preventive Medicine (ROCO:6810), the current ROCE % is -22.98% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio Preventive Medicine (ROCO:6810) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Preventive Medicine stock appears to be undervalued. The current stock price of NT$21.00 is trading 23.7% below its estimated GF Value™ of NT$27.53. GuruFocus considers Bio Preventive Medicine to be Modestly Undervalued.

Key valuation signals for ROCO:6810:

  • ROCE %: -22.98%
  • GF Value™: NT$27.53 vs. price of NT$21.00 (23.7% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6810 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio Preventive Medicine Business Description

Address No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is a clinical-stage biotech company, focusing on the early detection and prevention of diseases specialty of those high value-added molecular diagnostic products.
52GF Score

Get the complete analysis for ROCO:6810

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$21.00
Price
NT$27.53
GF Value